Literature DB >> 20842734

Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene.

Fransiska Malfait1, Delfien Syx, Philip Vlummens, Sofie Symoens, Sheela Nampoothiri, Trinh Hermanns-Lê, Lut Van Laer, Anne De Paepe.   

Abstract

We present clinical and molecular findings of three patients with an EDS VIB phenotype from two consanguineous families. The clinical findings of EDS kyphoscoliotic type (EDS type VIA and B) comprise kyphoscoliosis, muscular hypotonia, hyperextensible, thin and bruisable skin, atrophic scarring, joint hypermobility and variable ocular involvement. Distinct craniofacial abnormalities, joint contractures, wrinkled palms, and normal urinary pyridinoline ratios distinguish EDS VIB from EDS VIA. A genome-wide SNP scan and sequence analyses identified a homozygous frameshift mutation (NM_130468.2:c.145delG, NP_569735.1:p.Val49*) in CHST14, encoding dermatan-4-sulfotransferase 1 (D4ST-1), in two Turkish siblings. Subsequent sequence analysis of CHST14 identified a homozygous 20-bp duplication (NM_130468.2:c.981_1000dup, NP_569735.1:p.Glu334Glyfs*107) in an Indian patient. Loss-of-function mutations in CHST14 were recently reported in adducted thumb–clubfoot syndrome (ATCS). Patients with ATCS present similar craniofacial and musculoskeletal features as the EDS VIB patients reported here, but lack the severe skin manifestations. By identifying an identical mutation in patients with EDS VIB and ATCS, we show that both conditions form a phenotypic continuum. Our findings confirm that the EDS-variant associated with CHST14 mutations forms a clinical spectrum, which we propose to coin as “musculocontractural EDS” and which results from a defect in dermatan sulfate biosynthesis, perturbing collagen assembly.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842734     DOI: 10.1002/humu.21355

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  34 in total

1.  Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation.

Authors:  N C Voermans; M Kempers; M Lammens; N van Alfen; M C Janssen; C Bönnemann; B G van Engelen; B C Hamel
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

2.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

3.  Clinical utility gene card for: Ehlers-Danlos syndrome types I-VII and variants - update 2012.

Authors:  Karin Mayer; Ingo Kennerknecht; Beat Steinmann
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

4.  Mutational analysis of 12 patients with the phenotype of Ehlers-Danlos syndrome type VIB shows no linkage to the zinc transporter gene SLC39A13.

Authors:  Linda C Walker; Elizabeth M Ju; Heather N Yeowell
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

5.  Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.

Authors:  Matthias Baumann; Cecilia Giunta; Birgit Krabichler; Franz Rüschendorf; Nicoletta Zoppi; Marina Colombi; Reginald E Bittner; Susana Quijano-Roy; Francesco Muntoni; Sebahattin Cirak; Gudrun Schreiber; Yaqun Zou; Ying Hu; Norma Beatriz Romero; Robert Yves Carlier; Albert Amberger; Andrea Deutschmann; Volker Straub; Marianne Rohrbach; Beat Steinmann; Kevin Rostásy; Daniela Karall; Carsten G Bönnemann; Johannes Zschocke; Christine Fauth
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

Review 6.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

7.  Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

Authors:  Sevjidmaa Baasanjav; Lihadh Al-Gazali; Taishi Hashiguchi; Shuji Mizumoto; Bjoern Fischer; Denise Horn; Dominik Seelow; Bassam R Ali; Samir A A Aziz; Ruth Langer; Ahmed A H Saleh; Christian Becker; Gudrun Nürnberg; Vincent Cantagrel; Joseph G Gleeson; Delphine Gomez; Jean-Baptiste Michel; Sigmar Stricker; Tom H Lindner; Peter Nürnberg; Kazuyuki Sugahara; Stefan Mundlos; Katrin Hoffmann
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

Review 8.  Modifications of glycans: biological significance and therapeutic opportunities.

Authors:  Saddam M Muthana; Christopher T Campbell; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2012-01-11       Impact factor: 5.100

Review 9.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder.

Authors:  Fransiska Malfait; Ariana Kariminejad; Tim Van Damme; Caroline Gauche; Delfien Syx; Faten Merhi-Soussi; Sandrine Gulberti; Sofie Symoens; Suzanne Vanhauwaert; Andy Willaert; Bita Bozorgmehr; Mohamad Hasan Kariminejad; Nazanin Ebrahimiadib; Ingrid Hausser; Ann Huysseune; Sylvie Fournel-Gigleux; Anne De Paepe
Journal:  Am J Hum Genet       Date:  2013-05-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.